Nanobiotix | Income Statement
Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
184.90
967.50
265.50
1,558.10
252.00
116
Cost of Goods Sold (COGS) incl. D&A
-
188.30
-
-
-
-
Gross Income
-
779.20
-
-
-
-
SG&A Expense
9,562.90
12,202.30
20,797.30
26,840.00
28,305.10
32,977
EBIT
9,590.00
11,423.10
20,891.30
25,558.00
28,736.60
33,430
Non Operating Income/Expense
86.00
321.80
218.50
107.30
590.80
647
Interest Expense
24.60
55.70
59.50
102.20
108.40
847
Pretax Income
9,469.40
10,960.40
20,549.10
25,493.40
29,402.70
33,596
Income Tax
1,324.50
1,403.90
3,546.00
3,612.90
3,259.50
3,251
Consolidated Net Income
8,144.90
9,556.50
17,003.10
21,880.50
26,143.20
30,345
Net Income
8,144.90
9,556.50
17,003.10
21,880.50
26,143.20
30,345
Net Income After Extraordinaries
8,144.90
9,556.50
17,003.10
21,880.50
26,143.20
30,345
Net Income Available to Common
8,144.90
9,556.50
17,003.10
21,880.50
26,143.20
30,345
EPS (Basic)
0.69
0.74
1.20
1.43
1.50
1.55
Basic Shares Outstanding
11,761.40
12,868.90
14,139.20
15,278.00
17,482.50
19,620.20
EPS (Diluted)
0.69
0.74
1.20
1.43
1.50
1.55
Diluted Shares Outstanding
11,761.40
12,868.90
14,139.20
15,278.00
17,482.50
19,620.20
EBITDA
9,377.90
11,234.80
20,531.70
25,121.70
28,391.00
32,861
Other Operating Expense
-
-
-
160.20
337.90
-
Non-Operating Interest Income
59.10
196.60
183.20
59.50
33.00
34
About Nanobiotix
View Profile
